Skip to content
10-K/A

Annual Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-11-000015

← back to feed
Filed
Oct 19, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jun 30, 2011 111.55M sh
Cash And Equivalents FY 2011 · Jun 30, 2011 $8.68K
Cash And Equivalents FY 2011 · Jun 30, 2010 $7.98K
Stockholders Equity FY 2011 · Jun 30, 2011 −$1.97M
Stockholders Equity FY 2011 · Jun 30, 2010 −$1.49M
Total Liabilities restated FY 2011 · Jun 30, 2011 $1.96M
Total Liabilities FY 2011 · Jun 30, 2010 $1.5M
Current Assets FY 2011 · Jun 30, 2011 $16.89K
Current Assets FY 2011 · Jun 30, 2010 $11.65K
Net Income FY 2011 · Jun 30, 2011 −$121.86K
Net Income FY 2011 · Jun 30, 2011 −$1.67M
Net Income FY 2011 · Jun 30, 2010 −$117.22K
Net Income restated FY 2011 · Jun 30, 2009 −$94.34K
Operating Income FY 2011 · Jun 30, 2011 −$121.86K
Operating Income FY 2011 · Jun 30, 2011 $1.96M
Operating Income FY 2011 · Jun 30, 2010 −$117.22K
Operating Income FY 2011 · Jun 30, 2009 −$117.94K